Tuberculosis Clinical Trial
We did an open-label, partially randomized trial to evaluate the efficacy, safety and tolerability of a 4-month combined treatment compared to a 6-month control treatment in adult participants with drug-sensitive smear-positive pulmonary tuberculosis (ds tb) and a 6-month treatment in adult participants with drug resistant, smear positive pulmonary tuberculosis (dr-tb)
The challenge? Many sites lacked materials to perform monovenopuncture collection. In addition, high patient screening and enrolment rates made it hard for sites to manage kit supplies. Lastly, while all clinical reports were shared with the investigator, no system existed that alerted investigators of alert values.
Discover how our team of experts made this trial succeed.
Reach out to our experts and discover how we can help you advance your clinical trialContact Us